# STAT+: Utah plows ahead with more health AI pilots for prescriptions, women’s health > Source: > Published: 2026-10-05 16:00:14+00:00 Utah regulators on Monday announced a plan to allow an artificial intelligence product to evaluate patients and write new drug prescriptions without prior human review. A startup called Nolla Health will launch an AI-powered service in the state that will assess a patient for mild-to-moderate acne treatment using a structured intake and by analyzing photos of their skin. The product may determine whether one of a list of low-risk drugs is appropriate. In the first stages of the pilot, the decisions of the AI will be reviewed by a licensed clinician who will sign off on prescriptions, but Nolla may eventually be allowed to prescribe drugs without this review. The company last year announced [it raised](https://www.generalcatalyst.com/stories/seeding-the-future-with-nolla-health) $4.5 million from investors including General Catalyst, and Nolla aspires to direct treatment for a host of conditions using AI. The new pilot is part of a significant expansion of a closely watched “AI sandbox” program that allows Utah’s Office of Artificial Intelligence Policy, or OAIP, to waive regulations for companies that want to test AI products under state supervision. ## This article is exclusive to STAT+ subscribers ### Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+. Already have an account? [Log in](https://www.statnews.com/login/) [View All Plans](https://www.statnews.com/stat-plus/)